The news of Rosenblatt maintaining a Buy rating on Ambarella is positive for the stock. However, the lowering of the price target from $100 to $95 may create some uncertainty among investors, potentially offsetting the positive sentiment. As a result, the short-term impact on the stock price is neutral.